Alerus Financial’s ProShares Ultra Health Care RXL Stock Holding History

Alerus Financial’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,124	Closed	-$218K	–	533
2025 Q3	$218K	Buy	+5,124	New	+$207K	0.01%	171

Other funds holding RXL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Alerus Financial's RXL Position: Q4 2025 in Review

Alerus Financial sold out of ProShares Ultra Health Care (RXL) in Q4 2025, closing a stake of 5,124 shares — an estimated $218K sold.

Alerus Financial first reported a position in RXL in Q3 2025 and held it in 1 quarter. The position peaked at $218K in Q3 2025. 16 funds tracked by Wall St. Rank hold RXL as of Q4 2025.

Alerus Financial reported no remaining ProShares Ultra Health Care position as of Q4 2025 after selling out during the quarter.
Alerus Financial sold 5,124 ProShares Ultra Health Care shares in Q4 2025, an estimated $218K.
Alerus Financial first reported a position in ProShares Ultra Health Care in Q3 2025 and held it in 1 quarter.
Alerus Financial's ProShares Ultra Health Care position peaked at $218K in Q3 2025.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2025.

Based on Alerus Financial's 13F filing for Q4 2025, filed 13 Feb 2026.